Analysis Note
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Application
Spiramycin may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using liquid chromatography technique.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
Footnote
To see an example of a Certificate of Analysis for this material enter LRAB1418 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
General description
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
Spiramycin belongs to the macrolide group of antibiotics, widely used in the treatment of respiratory tract, skin and skin-structure, sexually transmitted, and various other infections. Spiramycin is derived from the culture filtrate of Streptomyces ambofaciens and its mode of action involves the exibition of antimicrobial activity by inhibiting ribosomal protein biosynthesis.
Other Notes
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
This product has met the following criteria to qualify for the following awards: